Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 1.18 is 90% below its 5-year average of 11.98, near the low end of its 5-year range (1.18–59.73).
As of the fiscal period ended Friday, October 31, 2025. 38.70% below its 12-month average of 1.92.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
1.18
EARNINGS PER SHARE (EPS) AVG TTM
1.92
EARNINGS PER SHARE (EPS) AVG 3Y
1.82
EARNINGS PER SHARE (EPS) AVG 5Y
11.98
EARNINGS PER SHARE (EPS) AVG 10Y
9.24
EARNINGS PER SHARE (EPS) AVG 15Y
4.34
EARNINGS PER SHARE (EPS) AVG 20Y
3.60
CURRENT VS TTM AVG
-38.70%
CURRENT VS 3Y AVG
-35.34%
CURRENT VS 5Y AVG
-90.15%
CURRENT VS 10Y AVG
-87.24%
CURRENT VS 15Y AVG
-72.79%
CURRENT VS 20Y AVG
-67.24%
The Cooper Companies, Inc.
Market Cap
$14.05B
Earnings Per Share (EPS)
1.18
TTM Avg
1.92
3Y Avg
1.82
5Y Avg
11.98
Market Cap
$14.92B
Earnings Per Share (EPS)
8.17
TTM Avg
5.85
3Y Avg
6.82
5Y Avg
7.06
Market Cap
$12.59B
Earnings Per Share (EPS)
-2.10
TTM Avg
-1.51
3Y Avg
-0.65
5Y Avg
0.36
Market Cap
$12.58B
Earnings Per Share (EPS)
5.96
TTM Avg
5.64
3Y Avg
5.43
5Y Avg
9.01
Market Cap
$15.94B
Earnings Per Share (EPS)
17.07
TTM Avg
14.35
3Y Avg
11.37
5Y Avg
9.10
Market Cap
$11.58B
Earnings Per Share (EPS)
-3.76
TTM Avg
-1.35
3Y Avg
4.03
5Y Avg
5.21
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $14.05B | 1.18 | 1.92 | 1.82 | 11.98 |
| Solventum Corporation (SOLV)vs › | $14.92B | 8.17 | 5.85 | 6.82 | 7.06 |
| DaVita Inc. (DVA)vs › | $15.37B | 9.94 | 10.37 | 8.56 | 8.35 |
| Baxter International Inc. (BAX)vs › | $12.59B | -2.10 | -1.51 | -0.65 | 0.36 |
| Align Technology, Inc. (ALGN)vs › | $12.58B | 5.96 | 5.64 | 5.43 | 9.01 |
| Revvity, Inc. (RVTY)vs › | $12.44B | 2.10 | 2.25 | 2.01 | 3.78 |
| Medpace Holdings, Inc. (MEDP)vs › | $15.94B | 17.07 | 14.35 | 11.37 | 9.10 |
| Insulet Corp. (PODD)vs › | $11.60B | 4.30 | 4.74 | 3.13 | 2.14 |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.58B | -3.76 | -1.35 | 4.03 | 5.21 |
| Bio-Techne Corporation (TECH)vs › | $11.28B | 0.69 | 0.77 | 1.27 | 1.25 |
Trailing EPS (TTM)
$1.18
Forward EPS (Est.)
$4.63
P/E Ratio
59.6
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-10-31 | 1.88 |
| 2024-10-31 | 1.97 |
| 2023-10-31 | 1.49 |
| 2022-10-31 | 1.96 |
| 2021-10-31 | 59.73 |
| 2020-10-31 | 4.86 |
| 2019-10-31 | 9.47 |
| 2018-10-31 | 2.85 |
| 2017-10-31 | 7.63 |
| 2016-10-31 | 5.65 |
| 2015-10-31 | 4.20 |
| 2014-10-31 | 5.61 |
| 2013-10-31 | 6.09 |
| 2012-10-31 | 5.18 |
| 2011-10-31 | 3.74 |
| 2010-10-31 | 2.48 |
| 2009-10-31 | 2.23 |
| 2008-10-31 | 1.46 |
| 2007-10-31 | -0.25 |
| 2006-10-31 | 1.49 |
| 2005-10-31 | 2.06 |
| 2004-10-31 | 2.83 |
| 2003-10-31 | 2.20 |
| 2002-10-31 | 1.60 |
| 2001-10-31 | 1.25 |
| 2000-10-31 | 1.02 |
| 1999-10-31 | 0.89 |
| 1998-10-31 | 1.35 |
| 1997-10-31 | 1.20 |
| 1996-10-31 | 0.72 |
